Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

ESPR - Esperion Therapeutics, Inc.

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Cy McCaffrey, Oct 13, 2016.

  1. Cy McCaffrey

    Cy McCaffrey Content Manager
    Staff Member

    Joined:
    Mar 29, 2016
    Messages:
    5,222
    Likes Received:
    1,195
    [​IMG]

    Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Its lead product candidate is ETC-1002 or Bempedoic acid, an inhibitor of ATP Citrate Lyase, an enzyme on the cholesterol biosynthesis pathway that is in Phase III long-term safety and tolerability study to treat patients with hypercholesterolemia whose LDL-C is not adequately controlled with low- and moderate-dose statins. Bempedoic acid inhibits cholesterol synthesis in the liver, decreases intracellular cholesterol, and up-regulates LDL-receptors, resulting in increased LDL-C clearance and reduced plasma levels of LDL-C. Esperion Therapeutics, Inc. was founded in 2008 and is headquartered in Ann Arbor, Michigan.
     
  2. Gil Oren

    Gil Oren Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    4,052
    Likes Received:
    836
    I was watching this stock last month waiting to see a solid move over $14, it could not do it.

    $12 support, $14 resistance is the current range here.
     
    Cy McCaffrey likes this.
  3. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    5,035
    Likes Received:
    1,137
    Nice pop

    upload_2016-10-13_7-13-42.png
     
    Cy McCaffrey likes this.
  4. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    604
    Likes Received:
    46
    $ESPR the data must be really good considering a huge drop in NASDAQ and weak action in IBB
     
  5. Gil Oren

    Gil Oren Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    4,052
    Likes Received:
    836
    After a massive run when it broke that $14 resistance, its finally coming back down today!
     
  6. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    604
    Likes Received:
    46
    Esperion Therapeutics given $25.00 PT by Needham & Company LLC. buy rating.
     
  7. Gil Oren

    Gil Oren Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    4,052
    Likes Received:
    836
    Stampede in here today!
     
  8. Gil Oren

    Gil Oren Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    4,052
    Likes Received:
    836
    Shares of Esperion Therapeutics (ESPR) jumped 32.2% to $31.30 after the Ann Arbor, Mich.-based lipid management company said the U.S. Food and Drug Administration"recently confirmed that Esperion's LDL-C lowering program is adequate to support approval of an LDL-C lowering indication for bempedoic acid."

    Esperion said it intends to submit a new drug application by the first half of 2019 for an LDL-C lowering indication based on the successful completion of the phase three clinical development program.
     
  9. stock1234

    stock1234 Active Member

    Joined:
    Apr 3, 2016
    Messages:
    908
    Likes Received:
    193
    WTH, I was hoping to get back in at some point after the 20% drop last Friday, guess I am too late now :p
     
  10. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    1,221
    Likes Received:
    318
    Daytraders having a field day here. You know, when daily shares traded matches total # of shares, you can see 100% moves in a day. And it's only 65% right now lol.
     
  11. Gil Oren

    Gil Oren Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    4,052
    Likes Received:
    836
    Crazy!

    I used to love trading stuff like this, but then I got older and more cautious.

    How about that GE? Great company! ;)
     
  12. Gil Oren

    Gil Oren Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    4,052
    Likes Received:
    836
  13. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    1,221
    Likes Received:
    318
    Yeah we missed 10% :(
    The problem with trading stuff like this is when you only trade stuff like this.
    GE is amazing. Been in the Dow a long time.
     
  14. fidelgeorge

    fidelgeorge Active Member

    Joined:
    Apr 15, 2016
    Messages:
    649
    Likes Received:
    29
    Shares of Esperion Therapeutics (ESPR) may see early strength after the lipid management company said the FDA confirmed that its LDL-C lowering program is adequate to support approval of an LDL-C lowering indication for bempedoic acid.
     
  15. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    604
    Likes Received:
    46
    $ESPR price target raised to $50 from $22 at JPMorgan, citing the company's "positive" regulatory update on bempedoic acid.
     
  16. Gil Oren

    Gil Oren Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    4,052
    Likes Received:
    836
    WOOOO!

    Who ever had the balls to buy this dip got paid big time!
     

Share This Page